Literature DB >> 9829910

Exon scanning of the entire TSC2 gene for germline mutations in 40 unrelated patients with tuberous sclerosis.

R L Beauchamp1, A Banwell, P McNamara, M Jacobsen, E Higgins, H Northrup, P Short, K Sims, L Ozelius, V Ramesh.   

Abstract

Tuberous sclerosis complex (TSC) is a dominantly inherited multisystem disorder resulting in the development of hamartomatous growths in many organs. Genetic heterogeneity has been demonstrated linking the familial cases to either TSC1 at 9q34.3, or TSC2 at 16p13.3. About two-thirds of the TSC cases are sporadic and appear to represent new mutations. While both genes are thought to account for all familial cases, with each representing approximately 50% of the mutations, the proportion of sporadic cases with mutations in TSC1 and TSC2 is yet to be determined. We have examined the entire coding sequence of the TSC2 gene in 20 familial and 20 sporadic cases and identified a total of twenty-one mutations representing 50% and 55% of familial and sporadic cases respectively. Our rate of mutation detection is significantly higher than other published reports. Twenty out of 21 mutations are novel and include 6 missense, 6 nonsense, 5 frameshifts, 2 splice alterations, a 34 bp deletion resulting in abnormal splicing, and an 18 bp deletion which maintains the reading frame. The mutations are distributed throughout the coding sequence with no specific hot spots. There is no apparent correlation between mutation type and clinical severity of the disease. Our results document that at least 50% of sporadic cases arise from mutations in the TSC2 gene. The location of the mutations described here, particularly the missense events, should be valuable for further functional analysis of this tumor suppressor protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9829910     DOI: 10.1002/(SICI)1098-1004(1998)12:6<408::AID-HUMU7>3.0.CO;2-P

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  11 in total

1.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors:  T Carsillo; A Astrinidis; E P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.

Authors:  A C Jones; M M Shyamsundar; M W Thomas; J Maynard; S Idziaszczyk; S Tomkins; J R Sampson; J P Cheadle
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

3.  Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.

Authors:  Y Niida; A O Stemmer-Rachamimov; M Logrip; D Tapon; R Perez; D J Kwiatkowski; K Sims; M MacCollin; D N Louis; V Ramesh
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

4.  Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic Spectrum.

Authors:  Doreen N Palsgrove; Yunjie Li; Christine A Pratilas; Ming-Tseh Lin; Aparna Pallavajjalla; Christopher Gocke; Angelo M De Marzo; Andres Matoso; George J Netto; Jonathan I Epstein; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2018-09       Impact factor: 6.394

5.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

6.  A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism.

Authors:  Tomotsugu Ichikawa; Akiko Wakisaka; Shigeru Daido; Soichiro Takao; Takashi Tamiya; Isao Date; Shoichi Koizumi; Yo Niida
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

7.  Determining the pathogenicity of patient-derived TSC2 mutations by functional characterization and clinical evidence.

Authors:  Elaine A Dunlop; Kayleigh M Dodd; Stephen C Land; Peter A Davies; Nicole Martins; Helen Stuart; Shane McKee; Chris Kingswood; Anand Saggar; Isabel Corderio; Ana Maria Duarte Medeira; Helen Kingston; Julian R Sampson; David Mark Davies; Andrew R Tee
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246

8.  Pattern of TSC1 and TSC2 germline mutations in Russian patients with tuberous sclerosis.

Authors:  Evgeny N Suspitsin; Grigoriy A Yanus; Marina Yu Dorofeeva; Tatiana A Ledashcheva; Nataliya V Nikitina; Galina V Buyanova; Elena V Saifullina; Anna P Sokolenko; Evgeny N Imyanitov
Journal:  J Hum Genet       Date:  2018-02-23       Impact factor: 3.172

9.  Molecular and clinical analyses of 84 patients with tuberous sclerosis complex.

Authors:  Chia-Cheng Hung; Yi-Ning Su; Shu-Chin Chien; Horng-Huei Liou; Chih-Chuan Chen; Pau-Chung Chen; Chia-Jung Hsieh; Chih-Ping Chen; Wang-Tso Lee; Win-Li Lin; Chien-Nan Lee
Journal:  BMC Med Genet       Date:  2006-09-18       Impact factor: 2.103

10.  Renal neoplasms in tuberous sclerosis mice are neurocristopathies.

Authors:  Uchenna Unachukwu; Takayuki Shiomi; Monica Goldklang; Kiran Chada; Jeanine D'Armiento
Journal:  iScience       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.